13F filer · CIK 1398346 ↗

Meitav Investment House Ltd

You are looking at Q2 2019. See the latest, Q3 2026 →

Reported value

$1.50B

−16% on the quarter before

Positions

428

119 new · 81 sold out

Top 10

36.2%

of the value

Est. gain

+$4.8M

on stocks held all quarter

Est. return

+0.4%

on those stocks since Q1 2019

Filed

Aug 14, 2019

On SEC EDGAR ↗

Positions as of Jun 30, 2019, from Meitav Investment House Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

New
Added
Cut
Same
Options

The 24 largest positions, 57% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2019. Striped tiles are options.

Synaptics Inc6.7%

Cubic Corp5.4%

Israel Chemicals Ltd4.6%

Curtiss Wright Corp4.2%

Ormat Technologies Inc4.1%

Stag Indl Inc3.2%

Ansys Inc2.3%

Galmed Pharmaceuticals Ltd2.0%

Pvh Corp1.9%

Danaher Corporation1.8%

Penumbra Inc1.8%

Urogen Pharma Ltd1.8%

United Technologies Corp1.7%

Alphabet1.7%

Sprint Corporation1.6%

Switch Inc1.5%

Supercom Ltd New1.5%

Cvs Health Corp1.5%

Kornit Digital Ltd1.4%

Stratasys Ltd1.4%

Wpp Plc New1.3%

Dycom Inds Inc1.3%

Check Point Software Tech Lt1.3%

Comtech Telecommunications C1.2%

Synaptics Inc6.7%

Cubic Corp5.4%

Israel Chemicals Ltd4.6%

Curtiss Wright Corp4.2%

Ormat Technologies Inc4.1%

Stag Indl Inc3.2%

Ansys Inc2.3%

Galmed Pharmaceuticals Ltd2.0%

Pvh Corp1.9%

Danaher Corporation1.8%

Penumbra Inc1.8%

Urogen Pharma Ltd1.8%

United Technologies Corp1.7%

Alphabet1.7%

Sprint Corporation1.6%

Switch Inc1.5%

Supercom Ltd New1.5%

Cvs Health Corp1.5%

Kornit Digital Ltd1.4%

Stratasys Ltd1.4%

Wpp Plc New1.3%

Dycom Inds Inc1.3%

Check Point Software Tech Lt1.3%

Comtech Telecommunications C1.2%

Largest buys

Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Cubic Corp~$67.8MAdded · 0.7% → 5.4%+868,891 shares
Wpp Plc New~$18.9MAdded · 0.0% → 1.3%+77,315 shares
Kornit Digital Ltd~$18.7MAdded · 0.1% → 1.4%+590,579 shares
Dbx ETF Tr~$16.8MNew · 0.0% → 1.1%+152,668 shares
Mellanox Technologies Ltd~$12.2MAdded · 0.1% → 1.0%+95,316 shares
Block H & R Inc~$11.8MNew · 0.0% → 0.8%+238,905 shares
Galmed Pharmaceuticals Ltd~$9.1MAdded · 1.3% → 2.0%+78,628 shares
Supercom Ltd New~$8.0MAdded · 0.7% → 1.5%+56,049 shares
Allergan Plc~$7.2MAdded · 0.1% → 0.6%+103,950 shares
Switch Inc~$7.0MAdded · 0.9% → 1.5%+110,037 shares

Largest sells

Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Ormat Technologies Inc~$62.6MCut · 6.7% → 4.1%−212,405 shares
Curtiss Wright Corp~$50.9MCut · 3.9% → 4.2%−814,588 shares
Stag Indl Inc~$25.2MCut · 4.0% → 3.2%−434,360 shares
Amazon~$24.5MCut · 1.5% → 0.3%−12,910 shares
Cisco~$23.5MCut · 1.5% → 0.3%−422,017 shares
Microsoft~$22.7MCut · 1.4% → 0.4%−169,257 shares
Cubesmart~$22.2MCut · 1.2% → 0.0%−286,740 shares
Ishares Tr~$21.9MSold out · 1.2% → 0.0%−622,358 shares
Globant S A~$20.5MCut · 1.0% → 0.1%−856,726 shares
Urogen Pharma Ltd~$19.8MCut · 3.9% → 1.8%−1,042,235 shares

Holdings

As of Jun 30, 2019. Changes are in shares against Mar 31, 2019, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
#	Holding		% prev	Value	Shares		Price	Prev price
1	Synaptics IncSBI INT-FINL · shares +2.7% · price +7.3%	6.7%	5.1%	$101.2M	3.7M	+2.7%	$27.59	$25.71	+7.3%	+$6.7M
2	Cubic CorpTECHNOLOGY · shares +520% · price +5.5%	5.4%	0.69%	$80.9M	1.0M	+520%	$78.07	$74.00	+5.5%	+$680,575
3	Israel Chemicals LtdSHS · shares −20% · price −6.4%	4.6%	5.2%	$69.1M	624,498	−20%	$110.73	$118.35	−6.4%	−$4.8M
4	Curtiss Wright CorpCOM · shares −44% · price +65.8%	4.2%	3.9%	$63.7M	1.0M	−44%	$62.46	$37.68	+65.8%	+$25.3M
5	Ormat Technologies IncCORE S&P500 ETF · shares −51% · price +3.6%	4.1%	6.7%	$61.2M	207,582	−51%	$294.80	$284.55	+3.6%	+$2.1M
6	Stag Indl IncSBI CONS STPLS · shares −34% · price +3.5%	3.2%	4.0%	$48.5M	835,443	−34%	$58.06	$56.11	+3.5%	+$1.6M
7	Ansys IncFTSE EMR MKT ETF · shares −24% · price +0.1%	2.3%	2.5%	$34.3M	806,237	−24%	$42.54	$42.50	+0.1%	+$32,920
8	Galmed Pharmaceuticals LtdORD · shares +42% · price −8.4%	2.0%	1.3%	$30.5M	263,867	+42%	$115.63	$126.29	−8.4%	−$2.0M
9	Pvh CorpEXPANDED TECH · shares −19% · price +3.7%	1.9%	1.8%	$27.8M	127,330	−19%	$218.59	$210.81	+3.7%	+$990,975
10	Danaher CorporationCOMM SRVC ETF · shares −18% · price +3.8%	1.8%	1.8%	$27.5M	316,512	−18%	$86.73	$83.52	+3.8%	+$1.0M
11	Penumbra IncCOM · shares +9.8% · price −8.5%	1.8%	1.5%	$27.4M	1.1M	+9.8%	$25.00	$27.31	−8.5%	−$2.3M
12	Urogen Pharma LtdSHS EURO · shares −43% · price −32.9%	1.8%	3.9%	$26.7M	1.4M	−43%	$19.02	$28.34	−32.9%	−$13.1M
13	United Technologies CorpCOM NEW · shares +1.6% · price −4.5%	1.7%	1.5%	$25.6M	146,988	+1.6%	$173.97	$182.08	−4.5%	−$1.2M
14	AlphabetCAP STK CL A · shares −14% · price −8.0%	1.7%	1.8%	$25.3M	23,378	−14%	$1,082.90	$1,176.58	−8.0%	−$2.2M
15	Sprint CorporationSBI HEALTHCARE · shares −35% · price +0.9%	1.6%	2.0%	$23.4M	252,457	−35%	$92.59	$91.75	+0.9%	+$210,524
16	Switch IncENERGY · shares +43% · price −3.7%	1.5%	0.94%	$23.2M	364,631	+43%	$63.68	$66.12	−3.7%	−$620,548
17	Supercom Ltd NewSHS · shares +52% · price +17.7%	1.5%	0.72%	$23.1M	162,850	+52%	$142.13	$120.79	+17.7%	+$2.3M
18	Cvs Health CorpUS HOME CONS ETF · shares −5.9% · price +8.5%	1.5%	1.3%	$22.8M	596,280	−5.9%	$38.23	$35.24	+8.5%	+$1.8M
19	Kornit Digital LtdSHS · shares +729% · price +32.9%	1.4%	0.11%	$21.2M	671,610	+729%	$31.63	$23.81	+32.9%	+$633,887
20	Stratasys LtdCOM · shares −0.05% · price −2.8%	1.4%	1.2%	$20.3M	565,548	−0.05%	$35.91	$36.94	−2.8%	−$581,918
21	Wpp Plc NewCOM · shares +2,209% · price +0.8%	1.3%	0.05%	$19.7M	80,815	+2,209%	$244.13	$242.29	+0.8%	+$6,439
22	Dycom Inds IncSHS · shares +1.9% · price −0.7%	1.3%	1.1%	$19.4M	3.7M	+1.9%	$5.23	$5.27	−0.7%	−$131,576
23	Check Point Software Tech LtSHS · shares −24% · price −1.1%	1.3%	1.4%	$19.4M	408,054	−24%	$47.50	$48.03	−1.1%	−$216,335
24	Comtech Telecommunications CCOM · shares +0.02% · price −6.7%	1.2%	1.1%	$18.2M	326,015	+0.02%	$55.84	$59.85	−6.7%	−$1.3M
25	Ceva IncCL A · shares +41% · price +20.5%	1.2%	0.58%	$17.5M	422,266	+41%	$41.43	$34.37	+20.5%	+$2.1M
	Total · 428 positions	100%		$1.50B						+$4.8M

The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2019 to Q2 2019: 309 stocks held throughout, up $4.8M (+0.4%).

Curtiss Wright Corp+$25.3M+66%
Synaptics Inc+$6.7M+7%
Supercom Ltd New+$2.3M+18%
Ormat Technologies Inc+$2.1M+4%
Ceva Inc+$2.1M+21%
Penumbra Inc−$2.3M−8%
Baidu−$3.8M−29%
Israel Chemicals Ltd−$4.8M−6%
Ituran Location And Control−$7.4M−41%
Urogen Pharma Ltd−$13.1M−33%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$20.00B$10.00B$0

Q4 201736 quartersQ3 2026

Every quarter's filing

Each quarter's 13F filing, newest first
Quarter	Filed	Reported value	Positions	Filing
Q3 2026	Oct 28, 2026	$15.54B+5%	298	SEC ↗
Q2 2026	Jul 20, 2026	$14.87B+63%	299	SEC ↗
Q1 2026	Apr 29, 2026	$9.12B+5%	232	SEC ↗
Q4 2025	Feb 10, 2026	$8.66B+14%	241	SEC ↗
Q3 2025	Oct 29, 2025	$7.57B+2%	236	SEC ↗
Q2 2025	Jul 23, 2025	$7.42B+37%	217	SEC ↗
Q1 2025	May 12, 2025	$5.43B−8%	216	SEC ↗
Q4 2024	Feb 3, 2025	$5.93B−1%	221	SEC ↗
Q3 2024	Oct 28, 2024	$5.97B+6%	227	SEC ↗
Q2 2024	Jul 29, 2024	$5.62B+10%	221	SEC ↗
Q1 2024	May 1, 2024	$5.10B−25%	230	SEC ↗
Q4 2023	Jan 29, 2024	$6.81B+10%	336	SEC ↗
Q3 2023	Oct 30, 2023	$6.17B−50%	334	SEC ↗
Q2 2023	Jul 24, 2023 (amended)	$12.45B+115%	648	SEC ↗
Q1 2023	May 11, 2023	$5.79B−1%	355	SEC ↗
Q4 2022	Feb 6, 2023	$5.82B+3%	356	SEC ↗
Q3 2022	Oct 31, 2022	$5.67B−3%	361	SEC ↗
Q2 2022	Aug 1, 2022	$5.86B−13%	335	SEC ↗
Q1 2022	May 9, 2022	$6.74B+10%	382	SEC ↗
Q4 2021	Feb 8, 2022	$6.14B+1%	383	SEC ↗
Q3 2021	Nov 3, 2021	$6.10B−22%	404	SEC ↗
Q2 2021	Aug 5, 2021 (amended)	$7.81B+119%	412	SEC ↗
Q1 2021	May 6, 2021	$3.57B+40%	379	SEC ↗
Q4 2020	Feb 2, 2021	$2.55B+27%	413	SEC ↗
Q3 2020	Nov 5, 2020	$2.02B+21%	394	SEC ↗
Q2 2020	Aug 10, 2020	$1.67B+25%	385	SEC ↗
Q1 2020	May 11, 2020	$1.34B−3%	376	SEC ↗
Q4 2019	Feb 10, 2020	$1.38B−1%	422	SEC ↗
Q3 2019	Nov 14, 2019	$1.39B−7%	441	SEC ↗
Q2 2019	Aug 14, 2019	$1.50B−16%	428	SEC ↗
Q1 2019	May 13, 2019	$1.78B+10%	390	SEC ↗
Q4 2018	Feb 13, 2019	$1.62B−21%	336	SEC ↗
Q3 2018	Nov 14, 2018	$2.05B−8%	441	SEC ↗
Q2 2018	Aug 14, 2018	$2.24B+14%	422	SEC ↗
Q1 2018	May 15, 2018	$1.97B+15%	338	SEC ↗
Q4 2017	Feb 15, 2018	$1.71B	201	SEC ↗